Topics

Teva, Iontas enter deal for biotherapeutics development

05:50 EDT 31 Jul 2019 | SmartBrief

Teva Pharmaceuticals and Iontas have partnered to optimize human antibodies to be used for biotherapeutics.  -More

Original Article: Teva, Iontas enter deal for biotherapeutics development

NEXT ARTICLE

More From BioPortfolio on "Teva, Iontas enter deal for biotherapeutics development"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...